JNK Gene and Antidepressants

     The Road Back Program

Main Content

JNK Gene and Antidepressants

Antidepressants are a class of drugs that are commonly used to treat depression and other mood disorders. They work by modulating the levels of certain neurotransmitters, such as serotonin, norepinephrine, and dopamine, in the brain. However, the exact mechanisms by which antidepressants exert their therapeutic effects are not fully understood. One possible mechanism involves the activation of the JNK gene and its downstream signaling pathway.

JNK (c-Jun N-terminal kinase) is a member of the mitogen-activated protein kinase (MAPK) family, which is involved in many cellular processes, including proliferation, differentiation, apoptosis, and stress responses. JNK is activated by various stimuli, such as cytokines, growth factors, and cellular stressors, including oxidative stress, DNA damage, and inflammation. Once activated, JNK phosphorylates and activates various transcription factors, such as c-Jun, ATF-2, and Elk-1, which regulate the expression of genes involved in cell survival, proliferation, and apoptosis.

Several studies have shown that antidepressants can activate the JNK signaling pathway in different cell types and animal models. For example, fluoxetine, a selective serotonin reuptake inhibitor (SSRI), has been shown to activate JNK in rat hippocampal neurons, human SH-SY5Y neuroblastoma cells, and mouse embryonic fibroblasts. Similarly, imipramine, a tricyclic antidepressant (TCA), has been shown to activate JNK in rat hippocampal neurons and human osteosarcoma cells. Other antidepressants, such as venlafaxine, bupropion, and mirtazapine, have also been shown to activate JNK in different cell types.

The activation of JNK by antidepressants has negative effects, such as the induction of apoptosis and the activation of pro-inflammatory pathways. The long-term effects of JNK activation by antidepressants on neuronal function and survival are not fully understood, and may depend on the dose, duration, and type of antidepressant used, as well as the individual patient characteristics.